Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) just unveiled an announcement.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. announced the payment of a special dividend to its shareholders, excluding the Offeror and its subsidiaries, scheduled for October 31, 2025. The company will adhere to the PRC Tax Law by withholding and paying the required income tax on dividends distributed to overseas non-resident enterprise and individual H Shareholders, with specific arrangements based on the shareholders’ country of domicile.
The most recent analyst rating on (HK:1558) stock is a Buy with a HK$13.80 price target. To see the full list of analyst forecasts on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H stock, see the HK:1558 Stock Forecast page.
More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a pharmaceutical company based in China, focusing on the development, production, and sale of pharmaceutical products. The company operates within the pharmaceutical industry, targeting both domestic and international markets.
Average Trading Volume: 9,585,534
Technical Sentiment Signal: Buy
Current Market Cap: HK$13.97B
Learn more about 1558 stock on TipRanks’ Stock Analysis page.